RAC 2.92% $1.94 race oncology ltd

Merry Christmas & Bright New Year, page-2

  1. 870 Posts.
    lightbulb Created with Sketch. 1076
    Merry Xmas & a Happy New Year to you Dr.T @Davisite and to all the team at RAC.

    Yes it's been a very frustrating couple of years, so very much anticipating and looking forward in 2024 and bisantrene performing in the clinic as it has in the preclinicals. I think most of us here have high hopes and expectations, so it almost feels like make or break coming up in 2024.

    I'm betting (not withstanding no guarantees of success) on you, the RAC team & collaborators making 2024 the year that Bisantrenes efficancy is further shown to be outstanding and the recognition from patients, the medical community, big pharma and the share market (ie SP) will be crystallized.

    Best wishes to all fellow shareholders and HC posters, I hope you make a motza in 2024 !


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.